Aim. The aim of the study was to investigate the endoscopic diagnostic and treatment techniques for biliary complications after
development, these complications occurred in 50% of patients [1] [2] [3] .
According to literature data, the mortality due to biliary complications ranges from 2 to 9.6% [4] [5] . With the improvement of surgical technique, suture material and the introduction of new microsurgical technologies, the incidence of these complications has decreased, but still remains at a fairly high level and varies within the range of 8-35% [6] [7] [8] .
The most common biliary complications after LT are strictures and biliary-biliary anastomosis (BBA) incompetence that are often combined with each other [5] . Post-transplant strictures of the bile ducts are usually classified into anastomotic biliary strictures (ABSs) and non-anastomotic (NABSs) strictures. ABSs are relatively short in the extent and respond quite well to endoscopic treatment (70-80% cases) [9] [10] [11] . NABSs often result from an ischemic and immunological damage, they are diffuse, refractory to endoscopic treatment, and characterized by a higher recurrence rate and a 3 high probability of the graft loss. In this regard, liver transplantation is the method of choice for NABS treatment [8, 12] .
The endoscopic retrograde cholangiopancreaticography (ERCPG)
yields an accurate diagnosis of the stricture level and anastomosis incompetence [13, 14] . The endoscopic treatment of post-OLT biliary strictures includes a repeated balloon dilatation, multiple biliary-duodenal stenting with one or more plastic stents or with a self-expanding stent [15] [16] [17] . However, in patients with a compensated stricture, the risk of recurrence remains high, making 18% [9] .
The study objective was to investigate the endoscopic diagnostic and treatment techniques for biliary complications after orthotopic liver transplantation, their efficacy and safety. days, mean at 13.9 ± 7.6 days.
Material and methods

In
ERCPG was performed in 33 patients; in one case, the examination was not performed due to the severity of the patient's condition. Four patients with NABS supposed refractory to endoscopic treatment were excluded from the study.
Thus, the endoscopic treatment was attempted in 29 patients, including 20 men and 9 women. The age of the patients varied from 31 to 62 years, the mean age being 48.9 ± 2.1 years.
The endoscopic treatment of ABS was performed using the method including the diagnostic ERCPG, endoscopic papillosphincterotomy (EPST), biliary-duodenal stenting or nasobiliary drainage and balloon dilatation.
All procedures were performed in an X-ray Operating Room using an intravenous sedation of the patient. Duodenoscopy was performed using a standard OLYMPUS TJF-160VR video duodenoscope. After the selective catheterization of bile ducts, the ERCPG and the final assessment of the stricture location and extent were performed. If the cannulation of the suprastenotic hepatico-choledochal department was not feasible, the "rendez-vous" technique was used. After an antegrade drainage of the biliary tract, a string was passed into the duodenum where it was captured with a polypectomy loop and led out through the endoscope channel.
Before the endoscopic treatment, papillosphincterotomy was mandatory to prevent the Wirsung's duct occlusion and to reduce the likelihood of post-operative pancreatitis. Nasobiliary drainage was performed in a patient displaying acute cholangitis manifestations (Fig. 1) .
For ABS dilatation, we used COOK dilatation balloons, 8 mm in diameter 5 when inflated. After expanding the "waist" of the balloon in the ABS area, an exposure equal to 0.5-1 minute was maintained, with a pressure in the balloon of 4-5 atm. Two to 3 dilatations were performed per one procedure.
Fig. 1 . Cholangiogram: Nasobiliary drainage in the lumen of the bile ducts
For biliary tract stenting, the plastic biliary-duodenal stents of 7-11.5Fr diameter and 8-13 cm length, and the self-expandable fully covered metal stents of 0.8-1 cm in diameter and 8 to 10 cm in length were used.
Depending on the technical task, after passing the guide along the string, the proximal edge of the plastic stent was set at 1.5-2 cm above the ABS or into a hepatic lobar duct (in bilateral biliary-duodenal stenting) in a way that the distal end of the stent protruded into the duodenal lumen for 1-1.5 cm (Fig. 2-3 ). The metal self-expanding stent was positioned at 1.5-2 cm proximally to the ABS, and the distal end protruded into the duodenal lumen for 1 cm. restenting with a metal self-expanding stent, the exposure was 4-6 months.
Criteria for endoscopic treatment efficacy included the resolution of biliary hypertension confirmed by mini-invasive instrumental diagnostic techniques (ultrasonography and others), and the duration of relapse-free course. The treatment outcomes were analyzed using standard descriptive 7 statistics methods. The duration of relapse-free course in patients with ABSs treated endoscopically was analyzed using the Kaplan-Meier method.
RESULTS
Among 29 patients, the ABS was detected in 21 (72.4%) patients, the ABS combined with BBA incompetence in 7 (24.1%); one more patient had a BBA incompetence (3.5%).
Transpapillary intervention was planned in 29 patients (100%).
Cannulation of the major duodenal papilla (MDP) was successful in 22 of them (75.8%); in 7 other cases (24.2%) the attempts to cannulate the MDP failed. However, in 2 cases (6.9%), the suprastenotic biliary tract drainage was achieved using the anteretrograde "rendez-vous" technique, which resulted in biliary-duodenal stenting with a plastic stent.
The endoscopic treatment was not feasible in 5 patients (17.2%). The suprastenotic bile duct drainage was impossible due to a stricture with a diameter of less than 0.1 cm, which was combined with a significant angular (S-shaped) deformity of the anastomosis area (Fig. 4) , which required surgical decompression.
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Fig. 4. Cholangiogram: the marked angulation of the biliary-biliary anastomosis area
Thus, the number of patients who underwent endoscopic treatment was 24, or 82.8% of the group with BBA complications.
Biliary-duodenal stenting was performed with a plastic stent in 15 patients (51.7%) (Fig. 5) , with a self-expanding fully covered metal stent in 2 (6.9%). Five patients (17.2%) underwent nasobiliary drainage to treat the acute cholangitis manifestations. After coping with purulent cholangitis 3-5 days later, the drainage was replaced with a plastic biliary-duodenal stent.
In 1 case (3.5%), the BBA incompetence without associated ABS, successfully resolved after biliary-duodenal stenting.
The plastic stent was replaced with a self-expanding one in 9 of 22 patients (40.9%) after a preliminary balloon dilatation of ABS (Fig. 5) . In 13 patients, the plastic stent was replaced with another stent of the similar type.
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Fig. 5 . Endoscopic photo: the distal edge of the plastic stent in the duodenum lumen
The mean period of the endoscopic treatment was 12 ± 1.9 months, the mean number of endoscopy procedures per patient was 2.5 ± 1.3 (from 1 to 6).
Owing to the staged endoscopic treatment, the ABS remission was achieved in 16 patients (55.1%), including 4 of them (13.8%) in whom BBA incompetence was successfully resolved, which accounted for 47.1% of all BBA area complications. The mean duration of relapse-free course was 40 ± 28 months (Fig. 6) . For a long time, the endoscopic treatment of biliary strictures, either post-LT ones or any others, was limited to the placement of plastic stents.
Thuluvath et al. [19] in their study demonstrated satisfactory treatment outcomes for the strictures that developed during the first posttransplant year 11 and were treated by making one or two balloon dilatations and choledoch stenting with a plastic stent, followed by its restenting every 2-3 months.
However, the main drawback of plastic stents currently used remains the occlusion that inevitably occurs at 3 to 6 months later, as reported in a number of studies. A planned replacement of the plastic stent is required every 3 months to avoid the adverse effect on the graft [20] ; meanwhile, the risk of complications, including infection-related ones, sill persists, especially in the immunocompromised patients who underwent OLT. 
Conclusions
1.
Endoscopic retrograde cholangiopancreatography remains a highly informative method for diagnosing all biliary complications after liver transplantation.
2.
Therapeutic tactics for biliary complications occurring in the biliary-biliary anastomosis area presupposes the priority of endoscopic treatment techniques. Modern methods of endoscopy and interventional radiology make it possible to successfully treat most cases of biliary strictures and the biliary-biliary anastomosis incompetence, thereby achieving good long-term results with a minimally invasive method.
3.
Endoscopic treatment enabled to restore the patency of biliarybiliary anastomosis in 70.8% of patients after orthotopic liver transplantation and provided the relapse-free period of anastomotic biliary strictures for more than 2-5 years.
4.
Inefficacy of endoscopic treatment is an indication to surgical intervention.
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